CAT and Insulin resistance: Moreover, miR-30b may exert its effects more prominently within the adipose or muscle tissues rather than in plasma, a possibility supported by literature highlighting its role in adipogenesis and insulin resistance [32,33].These findings indicate that CAT and miR-30b are less likely to serve as systemic biomarkers for CMDs in older individuals.